Crestline Management, LP logo

Crestline Management, LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Crestline Management, LP with $58.1M in long positions as of Q3 2025, 96% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$58.1M
Top 10 Concentration
100%
Top Sector
Healthcare (96%)
US Exposure
100%
Market Cap Focus
Mid Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 96.40%HealthcareTechnology: 3.60%
Healthcare
96.40%
Technology
3.60%

Industry Breakdown

2 industries across all sectors

Biotechnology: 96.38%BiotechnologySoftware - Application: 3.62%
Biotechnology
Healthcare
96.38%
Software - Application
Technology
3.62%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 85.26%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 11.13%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 3.62%
Mid Cap ($2B - $10B)
85.26%
Small Cap ($300M - $2B)
11.13%
Micro Cap ($50M - $300M)
3.62%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($58.1M)
3 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
20.3 quarters
Avg. Top 20
20.3 quarters
Avg. All Positions
20.3 quarters
Median Holding Period
17 quarters
Persistence Rate
100.0%
Persistent Holdings Weight
100.0%
Persistent Positions
3
Longest Held
Denali Therapeutics Inc. Common Stock logo
Denali Therapeutics Inc. Common StockDNLI - 31 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
33.33%
Largest Position
Denali Therapeutics Inc. Common Stock logo
Denali Therapeutics Inc. Common StockDNLI - 85.26%
Largest Ownership Stake
Denali Therapeutics Inc. Common Stock logo
Denali Therapeutics Inc. Common StockDNLI - 2.33%
Avg. Ownership Stake
2.09%
Ownership Stake >5%
0
Ownership Stake >1%
1

Historical (Since Q4 2014)

Avg. New Position
0.54%
Avg. Ownership Stake
4.65%
Largest Position
JUNO
JUNO THERAPEUTICS INC COMMON STOCKJUNO - 100.00% (Q3 2015)
Largest Ownership Stake
Aquestive Therapeutics, Inc. Common Stock logo
Aquestive Therapeutics, Inc. Common StockAQST - 28.64% (Q3 2018)

Portfolio Turnover

Current Quarter

Turnover Ratio
7.5%
Value Traded
$4.33M
Positions Added
0
Positions Exited
0

Historical (Since Q4 2014)

Avg. Turnover Ratio
85.1%
Avg. Positions Added
44
Avg. Positions Exited
69
Highest Turnover
2200.1%
Q1 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.